#
Title
1

Barriers to Kidney Transplantation in the United States

2

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome

3

APOL1 at the Plasma Membrane and Cytotoxicity

4

ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances

5

Temporal, Cell-Specific Angiopoietin-2 in CKD

6

Cardiovascular Effects of GLP-1 RA in Kidney Failure

7

ASN Kidney Translation Series: Artificial Intelligence in Nephrology

8

Subclinical Primary Aldosteronism and eGFR Decline

9

ASN Kidney Translation Series: Peritoneal Dialysis

10

PD Use in Health Service Areas, 2009–2020

11

ASN Kidney Translation Series: ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure

12

LCN2-Induced CLUH Inhibition Disrupts Mitochondria in Kidney

13

ASN Kidney Translation Series: Kidney Transplant Advances

14

Automatic Organ and Cyst Volumes in ADPKD

15

Coronary Disease Screening Prior to Kidney Transplant

16

ASN Kidney Translation Series: Advances in Glomerular Filtration Rate

17

Bone Marrow Inflammation Drives Glomerular Damage

18

ICD Code Accuracy for CVD in CKD

19

Dapagliflozin and HRQoL in Patients with CKD

20

ASN Kidney Translation Series: Glomerulonephritis

21

ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives

22

RNA Sequencing of IgA Nephropathy Kidneys

23

Alternative Splicing and Polyadenylation in Glomerular Disease

24

ASN Kidney Translation Series: Cardiovascular-Kidney Connection

25

The PEER-HD Randomized Controlled Trial

26

Disaster Management in Kidney Care

27

Regulation of Renal Glucose Handling by mTORC2

28

Drug Screening in Drosophila Nephrocytes

29

ASN Kidney Translation Series: ADPKD Advances

30

Anticoagulation in Dialysis Recipients with Atrial Fibrillation

31

CASR Determines Renal Response to Hypercalcemia

32

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury

33

ASN Kidney Translation Series: Kidney Stones

34

Molecular Signature of NPCs in the Catshark

35

Acetazolamide and the Kidney in T1D

36

Kidney Protection by Acetylcholine

37

ASN Kidney Translation Series: Genetic Testing in Nephrology

38

JASN Welcomes Basic Science Research

39

ASN Kidney Translation Series: Novel Therapies for IgA Nephropathy

40

Polycystin-2 Regulates Natriuretic Peptide Production

41

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

42

KLF15 Agonist in Kidney Disease

43

Stem Cells in Renovascular Disease

44

ASN Kidney Translation Series: Gender Equity in Nephrology

45

Complications of Uninephrectomy

46

JASN Welcomes Late-Breaking Clinical Trial Manuscript Submissions

47

sGC Activator Avenciguat for CKD

48

Absolute CKD Progression Risk

49

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury

50

Tubular Effect of Proteinuria

51

Set7 Regulates Glomerular Injury

52

Daprodustat and Heart Failure in CKD

53

Changes in ESKD Incidence

54

Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN

55

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

56

Kidney Transplant Registry Data: Advice for Users

57

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

58

Historical Redlining and the Incidence of Kidney Failure in US Cities

59

Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD

60

How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters

61

The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury

62

Urea and Uremia

63

Genomic Diagnostic Methods for CKD

64

Intensive BP Control and CKD Progression and Prognosis in Anti-GBM Disease

65

Pregnancy Risk for Kidney Patients; Cost Effectiveness Research in Dialysis

66

Use of Kidney Organoids to Study Steroid-Resistant Nephrotic Syndrome

67

Highlights in Renal Transplantation

68

Comparing Costs of Hemodialysis and Peritoneal Dialysis

69

Gender Differences in Care of CKD Patients

70

Climate Change: Implications for Nephrology

71

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

72

Addressing Racial and Ethnic Disparities in Kidney Disease

73

Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?

74

A New Approach to Advance Care Planning for Dialysis Decisions: Deciding not to Decide

75

JASN May 2022 Highlights: Inflammation as a Driver of CKD Progression

76

Roxadustat and the Interpretation of Non-Inferiority

77

The Renal Framingham - CVD Prediction

78

Lowering GFR to Protect GFR!

79

Insights into Collapsing Glomerulopathy

80

The Immune Responses to COVID-19 in Transplant Patients

81

JASN November 2021 Issue Highlights

82

JASN October 2021 Issue Highlights

83

New Directions for Clinical Trials in Kidney Disease

84

JASN August 2021 Issue Highlights

85

Lost Opportunities for Kidney Transplant

86

The Extracellular Matrix in Development, Aging, and Disease

87

Vaccine Acceptability and Hemodialysis Patients

88

COVID-19 Mortality and the Tough Discussions about Advance Care Planning

89

New Insights into the Mechanisms of Kidney Disease: Understanding Hypercholesterolemia in CKD; ADAM10 and Immune Injury to the Podocyte Slit Diaphragm

90

JASN May 2022 Issue Highlights

91

JASN April 2021 Issue Highlights

92

JASN March 2021 Issue Highlights

93

JASN February 2021 Issue Highlights

94

JASN January 2021 Issue Highlights

95

A Conversation with Mark Knepper and Josie Briggs: Does SARS-CoV2 Infect the Kidney?

96

A Dialogue with Mahboob Rahman and Erin Barreto About Ambulatory Blood Pressure Monitoring in Patients with Chronic Kidney Disease

97

A Discussion with Andrew Malone and Madhav Menon: RNAseq and the Transplant Biopsy, What is New?

98

A Conversation with Deidre Crews and Tanjala Purnell about COVID-19, Structural Racism and Kidney Disease